Le Lézard
Classified in: Health

Field Trip Health Ltd. to Participate in Upcoming Investor Conferences

TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's management team will participate in the following investor conferences in April 2022.

Sequire Cannabis & Psychedelic Virtual Conference:
Date: April 20 at 3:00pm ET
Registration & Webcast: Click Here

KCSA Virtual Psychedelics Conference:
Date: April 27 at 10:00am ET
Registration & Webcast: Click Here
The webcast recording will also be accessible on Field Trip's investor relations website and be found here.

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

Institutional investors interested in scheduling a meeting with Field Trip's management team, please contact KCSA Strategic Communications at [email protected].

About Field Trip Health Ltd.

Field Trip is a global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics and our Field Trip Health division building centres for psychedelic therapies opening across North America and Europe along with the digital and technological tools that will enable massive scale, we help people in need with a simple, evidence-based way to heal and heighten engagement with the world.

Learn more at https://www.meetfieldtrip.comhttps://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

Follow us on Twitter and Instagram: @fieldtriphealth.

To receive company updates about Field Trip and to be added to the email distribution list please sign up here.

Cautionary Note Regarding Forward-Looking Information 

This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding Field Trip and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of Field Trip and are based on assumptions and subject to risks and uncertainties. Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including those set forth in the Company's Annual Information Form and other market conditions, economic factors, management's ability to manage and to operate the business and the equity markets generally. Although Field Trip has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Field Trip does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to Field Trip, including its Annual Information Form, can be located on the SEDAR website at www.sedar.com and on the EDGAR section of the SEC's website at www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities.

Neither the Toronto Stock Exchange, nor its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.


Media contacts:
Rachel Moskowitz
Autumn Communications
[email protected]

Investor contacts:
Kathleen Heaney / Sophia Bashford / Tim Regan
KCSA Strategic Communications
[email protected]

SOURCE Field Trip Health Ltd.

These press releases may also interest you

at 06:05
SimBioSys, the precision oncology company behind the 4D Tumor Modelingtm technology, is presenting their latest breast cancer research and introducing new technology applications at the 2022 San Antonio Breast Cancer Symposium (SABCS). SimBioSys will...

at 06:05
Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that it has...

at 06:05
NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced the first commercial shipment of the CosMxtm Spatial Molecular Imager (SMI) and the AtoMxtm Spatial Informatics...

at 06:05
Molecular Targeting Technologies, Inc. (MTTI) announces the issuance of Chinese Patent CN109153641B covering MTTI's lead radiotherapeutic product, EBTATEtm and others in its EvaTheratm platform. Approval of "Chemical conjugates of Evans blue...

at 06:00
As Canada's health system crisis continues, the Canadian Medical Association (CMA) and a panel of experts will examine how health care is delivered across the country in the second installment of Health Summit Series: Bold Choices in Health Care, a...

at 06:00
Today, The Leapfrog Group announced the 2022 recipients of its annual Top Hospital Award and Top Ambulatory Surgery Center (ASC) Award, a national recognition widely acknowledged as one of the most competitive awards United States hospitals and ASCs...

News published on 18 april 2022 at 09:00 and distributed by: